74 related articles for article (PubMed ID: 29489879)
1. Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy.
Kim MJ; Lee WY; Choe YH
Gut Liver; 2015 May; 9(3):370-80. PubMed ID: 25071071
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in the misdiagnosis rates between Crohn's disease and intestinal tuberculosis.
Seo H; Lee S; So H; Kim D; Kim SO; Soh JS; Bae JH; Lee SH; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
World J Gastroenterol; 2017 Sep; 23(34):6306-6314. PubMed ID: 28974897
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of Crohn's disease and intestinal tuberculosis based on ATR-FTIR spectroscopy combined with machine learning.
Li YP; Lu TY; Huang FR; Zhang WM; Chen ZQ; Guang PW; Deng LY; Yang XH
World J Gastroenterol; 2024 Mar; 30(10):1377-1392. PubMed ID: 38596500
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn's disease.
Qiao YQ; Huang ML; Xu AT; Zhao D; Ran ZH; Shen J
J Biomed Sci; 2013 Dec; 20(1):87. PubMed ID: 24289115
[TBL] [Abstract][Full Text] [Related]
5. The FOXP3
Kosinsky RL; Gonzalez MM; Saul D; Barros LL; Sagstetter MR; Fedyshyn Y; Nair A; Sun Z; Hamdan FH; Gibbons HR; Perez Pachon ME; Druliner BR; Johnsen SA; Faubion WA
Gastroenterology; 2024 Apr; 166(4):631-644.e17. PubMed ID: 38211712
[TBL] [Abstract][Full Text] [Related]
6. Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn's disease, in comparison to intestinal tuberculosis.
Das P; Rampal R; Udinia S; Kumar T; Pilli S; Wari N; Ahmed IK; Kedia S; Gupta SD; Kumar D; Ahuja V
Intest Res; 2018 Jul; 16(3):426-435. PubMed ID: 30090042
[TBL] [Abstract][Full Text] [Related]
7. Evaluating CD4 and Foxp3 mRNA Expression in Tissue Specimens of Celiac Disease and Colorectal Cancer Patients.
Asri N; Nazemalhosseini Mojarad E; Taleghani MY; Houri H; Saeedi Niasar M; Rezaei-Tavirani M; Jahani-Sherafat S; Shahbazkhani A; Nikzamir A; Ehsani Ardakani MJ; Khodadost M; Rostami-Nejad M
Asian Pac J Cancer Prev; 2024 Feb; 25(2):647-652. PubMed ID: 38415552
[TBL] [Abstract][Full Text] [Related]
8. Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn's Disease, Intestinal Tuberculosis, and Behcet's Disease.
Yoo JW; Jo SI; Shin DW; Park JW; Kim SE; Lim H; Kang HS; Moon SH; Kim MK; Kim SY; Hwang SW; Soh JS
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761270
[TBL] [Abstract][Full Text] [Related]
9. Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review.
Choudhury A; Dhillon J; Sekar A; Gupta P; Singh H; Sharma V
BMC Gastroenterol; 2023 Jul; 23(1):246. PubMed ID: 37468869
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the diagnosis of intestinal tuberculosis.
Maulahela H; Simadibrata M; Nelwan EJ; Rahadiani N; Renesteen E; Suwarti SWT; Anggraini YW
BMC Gastroenterol; 2022 Mar; 22(1):89. PubMed ID: 35227196
[TBL] [Abstract][Full Text] [Related]
11. A combination of circulating microRNA-375-3p and chemokines CCL11, CXCL12, and G-CSF differentiate Crohn's disease and intestinal tuberculosis.
Roy S; Ghosh S; Banerjee M; Laha S; Bhattacharjee D; Sarkar R; Ray S; Banerjee A; Ghosh R; Halder A; Ghosh A; Chatterjee R; Datta S; Dhali GK; Banerjee S
Sci Rep; 2021 Dec; 11(1):23303. PubMed ID: 34857759
[TBL] [Abstract][Full Text] [Related]
12. Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time.
Téllez-Navarrete NA; Ramon-Luing LA; Muñoz-Torrico M; Preciado-García M; Medina-Quero K; Hernandez-Pando R; Chavez-Galan L
Mol Med; 2021 Jul; 27(1):76. PubMed ID: 34261449
[TBL] [Abstract][Full Text] [Related]
13. Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis.
Kedia S; Sharma R; Vuyyuru SK; Madhu D; Sahu P; Kante B; Das P; Goyal A; Madan K; Makharia G; Ahuja V
Intest Res; 2022 Apr; 20(2):184-191. PubMed ID: 33934587
[TBL] [Abstract][Full Text] [Related]
14. Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion.
Kedia S; Ahuja V
JGH Open; 2021 Feb; 5(2):177-179. PubMed ID: 33553652
[No Abstract] [Full Text] [Related]
15. Differentiating Crohn's disease from intestinal tuberculosis.
Kedia S; Das P; Madhusudhan KS; Dattagupta S; Sharma R; Sahni P; Makharia G; Ahuja V
World J Gastroenterol; 2019 Jan; 25(4):418-432. PubMed ID: 30700939
[TBL] [Abstract][Full Text] [Related]
16. CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
Tiwari V; Kedia S; Garg SK; Rampal R; Mouli VP; Purwar A; Mitra DK; Das P; Dattagupta S; Makharia G; Acharya SK; Ahuja V
PLoS One; 2018; 13(2):e0193433. PubMed ID: 29489879
[TBL] [Abstract][Full Text] [Related]
17. Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease.
Rampal R; Kedia S; Wari MN; Madhu D; Singh AK; Tiwari V; Mouli VP; Mohta S; Makharia G; Ahuja V
Intest Res; 2021 Apr; 19(2):232-238. PubMed ID: 32375209
[TBL] [Abstract][Full Text] [Related]
18. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
